Leveraging the national cancer institute's collaborative efforts to understand the benefits and harms of cannabis use among individuals with cancer.
Publication/Presentation Date
2-26-2026
Abstract
Cannabis use for symptom management among patients with cancer has increased significantly in recent years, with many reporting benefits for pain, anxiety, sleep, nausea, appetite as well as other symptoms. However, rigorous prospective data on the potential benefits and harms of cannabis use in this population are lacking. This Commentary describes a United States National Cancer Institute (NCI)-led initiative addressing this research gap by supporting five prospective observational studies evaluating the benefits and harms of cannabis use among a large, heterogeneous samples of patients with cancer undergoing active systemic treatment. We provide an overview of each study, including cancer type, treatment modalities, inclusion/exclusion criteria, data collection methods, and both patient-reported and cancer-related outcomes.
ISSN
1460-2105
Published In/Presented At
Nugent, S. M., Ashare, R. L., Cullen, J., Haque, R., Hu, J., Lee, R. T., Meghani, S. H., Potosky, A. L., Reboussin, B. A., Romero-Sandoval, A., Wagoner, K. G., Wang, Y., Worster, B., Filipski, K. K., & Freedman, A. N. (2026). Leveraging the national cancer institute's collaborative efforts to understand the benefits and harms of cannabis use among individuals with cancer. Journal of the National Cancer Institute, djag057. Advance online publication. https://doi.org/10.1093/jnci/djag057
Disciplines
Medicine and Health Sciences
PubMedID
41746285
Department(s)
Hematology-Medical Oncology Division
Document Type
Article